Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06384807 · ClinicalTrials.gov registry record · Phase 1

A Phase 1/2 Study of BHV-1510 (Previously PBI-410) in Advanced Solid Tumors

A Phase 1 study of Solid Tumor, sponsored by Biohaven Therapeutics.

Recruiting
Registry status
Phase 1
Development phase
500
Enrollment target
17
Study locations

NCT06384807 is a Phase 1 study of Solid Tumor that is actively recruiting participants, run by Biohaven Therapeutics. The registered enrollment target is 500 participants, above the 219-participant average among 196 other Solid Tumor trials with a reported enrollment target (128% higher). The trial reports 17 study locations across 13 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06384807, a Phase 1 study of Solid Tumor, is actively recruiting participants, sponsored by Biohaven Therapeutics.

RECRUITING
Registry status
Phase 1
Development phase
500 participants
Enrollment target
17
Study locations

Study Summary

This is a Phase 1/2, first in human (FIH), open-label, multicenter study of BHV-1510 monotherapy and in Combination with Cemiplimab in participants with previously treated, advanced solid tumors.

Conditions Studied

Solid Tumor

Interventions

  • DRUG Cemiplimab
  • DRUG BHV-1510

Study Locations (17)

California

  • Site-113 - Duarte
  • Site-112 - La Jolla
  • Site-111 - Palo Alto

Florida

  • Site-103 - Miami
  • Site-105 - Orlando
  • Site-115 - Tampa

District of Columbia

  • Site-114 - Washington D.C.

Georgia

  • Site-110 - Augusta

Michigan

  • Site-109 - Detroit

Missouri

  • Site-101 - St Louis

New York

  • Site-117 - New York

Oklahoma

  • Site-116 - Oklahoma City

Trial Details

FieldValue
Enrollment Target 500 participants
Start Date 2024-04-22
Est. Completion 2028-02
Phase Phase 1

Sponsor

Biohaven Therapeutics

16 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT06384807

The ClinicalTrials.gov registry entry for NCT06384807 describes a study currently listed as recruiting, categorized as Phase 1. The registered enrollment target is 500 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 219-participant average among 196 other Solid Tumor trials with a reported enrollment target (128% higher). The listed sponsor is Biohaven Therapeutics, which has 16 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Solid Tumor appearing as the primary indexed condition, and to 2 interventions - of which Cemiplimab is the first listed.

NCT06384807 reports 17 study locations spanning 13 distinct geographic areas - top geographies include California, Florida, District of Columbia.

Frequently Asked Questions

What is clinical trial NCT06384807 about?

NCT06384807 is a clinical study titled "A Phase 1/2 Study of BHV-1510 (Previously PBI-410) in Advanced Solid Tumors". This is a Phase 1/2, first in human (FIH), open-label, multicenter study of BHV-1510 monotherapy and in Combination with Cemiplimab in participants with previously treated, advanced solid tumors.

What is the current status of trial NCT06384807?

This trial is currently recruiting. It is a Phase 1 study. The enrollment target is 500 participants. The study started on 2024-04-22. Estimated completion is 2028-02.

What conditions does trial NCT06384807 study?

This clinical trial studies the following conditions: Solid Tumor.

What interventions are being tested in trial NCT06384807?

The interventions under investigation include: Cemiplimab (DRUG), BHV-1510 (DRUG).

Who is sponsoring clinical trial NCT06384807?

This trial is sponsored by Biohaven Therapeutics, which has 16 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06384807 being conducted?

This trial has 17 study locations across California, District of Columbia, Florida, Georgia, Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Solid Tumor

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Solid Tumor

All registered trials for this condition

California

All trials with a study site in California

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.